Technical Analysis for VNDA - Vanda Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade F 15.29 -5.56% -0.90
VNDA closed down 5.56 percent on Friday, May 17, 2019, on 86 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical VNDA trend table...

Date Alert Name Type % Chg
Evening Star Bearish 0.00%
New 52 Week Closing Low Bearish 0.00%
BB Squeeze Ended Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
20 DMA Resistance Bearish -5.56%
Shooting Star Candlestick Bearish -5.56%
Bollinger Band Squeeze Range Contraction -5.56%
Gapped Up Strength -5.56%
Up 3 Days in a Row Strength -5.56%
Bollinger Band Squeeze Range Contraction -4.38%

Older signals for VNDA ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Vanda Pharmaceuticals, Inc., a biopharmaceutical company, offers development and commercialization of products for the treatment of central nervous system disorders. The company provides Fanapt, a compound for the treatment of schizophrenia; and VLY-686, a small molecule neurokinin-1 receptor (NK-1R) antagonist that has indications for chemotherapy-induced nausea and vomiting, post-operative nausea and vomiting, alcohol dependence, anxiety, depression, and pruritus. Its product in clinical development includes Tasimelteon, which completed Phase III clinical trials for the treatment of circadian rhythm sleep disorders, as well as completed Phase IIb/III trials for the treatment of major depressive disorder and insomnia. Vanda Pharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Washington, District of Columbia.
Biopharmaceutical Chemical Compounds Organic Compounds Oncology Chemotherapy Schizophrenia Central Nervous System Disorders Depression Major Depressive Disorder Pyridines Nausea Treatment Of Major Depressive Disorder Vomiting Pruritus Treatment Of Central Nervous System Disorders Sedatives Chemotherapy Induced Nausea Fanapt Iloperidone Insomnia
Is VNDA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 33.44
52 Week Low 13.665
Average Volume 652,298
200-Day Moving Average 21.5539
50-Day Moving Average 17.4098
20-Day Moving Average 16.314
10-Day Moving Average 16.042
Average True Range 0.6893
ADX 36.74
+DI 15.7375
-DI 34.092
Chandelier Exit (Long, 3 ATRs ) 15.3721
Chandelier Exit (Short, 3 ATRs ) 15.7329
Upper Bollinger Band 17.3552
Lower Bollinger Band 15.2728
Percent B (%b) 0.01
BandWidth 12.764497
MACD Line -0.5284
MACD Signal Line -0.5519
MACD Histogram 0.0235
Fundamentals Value
Market Cap 685.88 Million
Num Shares 44.9 Million
EPS -0.23
Price-to-Earnings (P/E) Ratio -66.48
Price-to-Sales 4.05
Price-to-Book 4.81
PEG Ratio -2.09
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.61
Resistance 3 (R3) 16.75 16.45 16.39
Resistance 2 (R2) 16.45 16.11 16.38 16.32
Resistance 1 (R1) 15.87 15.91 15.72 15.73 16.24
Pivot Point 15.57 15.57 15.50 15.50 15.57
Support 1 (S1) 14.99 15.23 14.84 14.85 14.34
Support 2 (S2) 14.69 15.03 14.62 14.26
Support 3 (S3) 14.11 14.69 14.19
Support 4 (S4) 13.97